These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 17479341)

  • 21. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
    Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
    J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary reverse mapping for breast cancer.
    Noguchi M
    Breast Cancer Res Treat; 2010 Feb; 119(3):529-35. PubMed ID: 19842033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
    J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
    Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
    PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
    Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
    [No Abstract]   [Full Text] [Related]  

  • 26. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
    Boneti C; Badgwell B; Robertson Y; Korourian S; Adkins L; Klimberg V
    Minerva Ginecol; 2012 Oct; 64(5):421-30. PubMed ID: 23018481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
    Ikeda K; Ogawa Y; Komatsu H; Mori Y; Ishikawa A; Nakajima T; Oohira G; Tokunaga S; Fukushima H; Inoue T
    World J Surg Oncol; 2012 Nov; 10():233. PubMed ID: 23116152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
    Pavlista D; Eliška O
    Ceska Gynekol; 2012 Jun; 77(3):251-4. PubMed ID: 22779729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla -- a lesson from the past -- contribution to the concept of axillary reverse mapping.
    Pavlista D; Eliska O
    Eur J Surg Oncol; 2012 May; 38(5):390-4. PubMed ID: 22336143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection.
    Nos C; Kaufmann G; Clough KB; Collignon MA; Zerbib E; Cusumano P; Lecuru F
    Ann Surg Oncol; 2008 Sep; 15(9):2550-5. PubMed ID: 18618185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.
    Beek MA; Gobardhan PD; Schoenmaeckers EJ; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
    Breast Cancer Res Treat; 2016 Aug; 158(3):421-32. PubMed ID: 27444925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA; Peng J; He Y; Chen J; Cen Y
    Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
    Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
    Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
    Kavallaris A; Camara O; Runnebaum IB
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.